Baicalin exerts protective effects against lipopolysaccharide-induced acute lung injury by regulating the crosstalk between the CX3CL1-CX3CR1 axis and NF-B pathway in CX3CL1-knockout mice

International Journal of Molecular Medicine

Volumn 37, Issue 3, 2016, Pages 703-715

  Ding, Xin Min ^a   Pan, Lei ^a   Wang, Yong ^a   Xu, Qin Zhi ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Acute lung injury; Baicalin; CX3CL1 CX3CR1 axis; CX3CL1 knockout; Inflammation; Nuclear factor B

Indexed keywords

BAICALIN; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN KINASE B; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CHEMOKINE RECEPTOR; CX3CL1 PROTEIN, MOUSE; CX3CR1 PROTEIN, MOUSE; FLAVONOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LIPOPOLYSACCHARIDE-INDUCED ACUTE LUNG INJURY; LUNG WEIGHT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE; ACUTE LUNG INJURY; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CHEMICALLY INDUCED; DRUG EFFECTS; KNOCKOUT MOUSE; METABOLISM; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ACUTE LUNG INJURY; ANIMALS; CELLS, CULTURED; CHEMOKINE CX3CL1; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLAVONOIDS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NF-KAPPA B; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION;

EID: 84959192181     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2016.2456     Document Type: Article

References (37)

1. Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM, Scales DC, Stather DR, Li A, Jones A, et al: Has mortality from acute respiratory distress syndrome decreased over time?: a systematic review. Am J Respir Crit Care Med 179: 220-227, 2009.
2. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ and Hudson LD: Incidence and outcomes of acute lung injury. N Engl J Med 353: 1685-1693, 2005.
3. Muñoz NM, Meliton AY, Meliton LN, Dudek SM and Leff AR: Secretory group V phospholipase A2 regulates acute lung injury and neutrophilic inflammation caused by LPS in mice. Am J Physiol Lung Cell Mol Physiol 296: L879-L887, 2009.
4. Xu XL, Xie QM, Shen YH, Jiang JJ, Chen YY, Yao HY and Zhou JY: Mannose prevents lipopolysaccharide-induced acute lung injury in rats. Inflamm Res 57: 104-110, 2008.
5. Matthay MA and Zemans RL: The acute respiratory distress syndrome: Pathogenesis and treatment. Annu Rev Pathol 6: 147-163, 2011.
6. Ware LB and Matthay MA: The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349, 2000.
7. Li B, Yang J, Huang Q, Zhang Y, Peng C, Zhang Y, He Y, Shi J, Li W, Hu J, et al: Biodistribution and pulmonary toxicity of intratracheally instilled graphene oxide in mice. NPG Asia Mater 5: e44, 2013.
8. Spragg RG, Bernard GR, Checkley W, Curtis JR, Gajic O, Guyatt G, Hall J, Israel E, Jain M, Needham DM, et al: Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med 181: 1121-1127, 2010.
9. Lam CW, James JT, McCluskey R and Hunter RL: Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 77: 126-134, 2004.
10. Song Y, Fukuda N, Bai C, Ma T, Matthay MA and Verkman AS: Role of aquaporins in alveolar fluid clearance in neonatal and adult lung, and in oedema formation following acute lung injury: studies in transgenic aquaporin null mice. J Physiol 525: 771-779, 2000.
11. Martin TR and Matute-Bello G: Experimental models and emerging hypotheses for acute lung injury. Crit Care Clin 27: 735-752, 2011.
12. Reiss LK, Uhlig U and Uhlig S: Models and mechanisms of acute lung injury caused by direct insults. Eur J Cell Biol 91: 590-601, 2012.
13. Liu L, Gao Z, Xia C, Xu Y, Ma Z, Dong C and Li B: Comparative study of trans-oral and trans-tracheal intratracheal instillations in a murine model of acute lung injury. Anat Rec (Hoboken) 295: 1513-1519, 2012.
14. Su X, Bai C, Hong Q, Zhu D, He L, Wu J, Ding F, Fang X and Matthay MA: Effect of continuous hemofiltration on hemodynamics, lung inflammation and pulmonary edema in a canine model of acute lung injury. Intensive Care Med 29: 2034-2042, 2003.
15. Matthay MA, Ware LB and Zimmerman GA: The acute respiratory distress syndrome. J Clin Invest 122: 2731-2740, 2012.
16. Evers DL, Chao CF, Wang X, Zhang Z, Huong SM and Huang ES: Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action. Antiviral Res 68: 124-134, 2005.
17. Wan QF, Gu LG, Yin SJ, Qi GJ, Zhang S, Li GM and Ge DY: Protection effect of baicalin on lung injury of mice infected with influenza FM1. Chin J Tradit Chin Med Pharm: 2848-2851, 2011 (In Chinese).
18. Wan QF, Gu LG, Yin SJ, Ge DY and Li GM: Effect of baicalin on cell apoptosis FAS/FAS-L system of pneumonia mice lung tissue infected with FM1. Chin Pharmacol Bull 27: 1555-1559, 2011 (In Chinese).
19. Vergadi E, Vaporidi K, Theodorakis EE, Doxaki C, Lagoudaki E, Ieronymaki E, Alexaki VI, Helms M, Kondili E, Soennichsen B et al: Akt2 deficiency protects from acute lung injury via alternative macrophage activation and miR-146a induction in mice. J Immunol 192: 394-406, 2014.
20. Balakrishna S, Song W, Achanta S, Doran SF, Liu B, Kaelberer MM, Yu Z, Sui A, Cheung M, Leishman E, et al: TRPV4 inhibition counteracts edema and inflammation and improves pulmonary function and oxygen saturation in chemically induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 307: L158-L172, 2014.
21. Wasmuth HE, Zaldivar MM, Berres ML, Werth A, Scholten D, Hillebrandt S, Tacke F, Schmitz P, Dahl E, Wiederholt T, et al: The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection. J Hepatol 48: 208-215, 2008.
22. Aoyama T, Inokuchi S, Brenner DA and Seki E: CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice. Hepatology 52: 1390-1400, 2010.
23. Isse K, Harada K, Zen Y, Kamihira T, Shimoda S, Harada M and Nakanuma Y: Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Hepatology 41: 506-516, 2005.
24. Zhuang ZY, Kawasaki Y, Tan PH, Wen YR, Huang J and Ji RR: Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun 21: 642-651, 2007.
25. Lee KM, Jeon SM and Cho HJ: Interleukin-6 induces microglial CX3CR1 expression in the spinal cord after peripheral nerve injury through the activation of p38 MAPK. Eur J Pain 14: 682.e1-12, 2010.
26. Nishiyori A, Minami M, Ohtani Y, Takami S, Yamamoto J, Kawaguchi N, Kume T, Akaike A and Satoh M: Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett 429: 167-172, 1998.
27. Andréasson U, Ek S, Merz H, Rosenquist R, Andersen N, Jerkeman M, Dictor M and Borrebaeck CA: B cell lymphomas express CX3CR1 a non-B cell lineage adhesion molecule. Cancer Lett 259: 138-145, 2008.
28. Erreni M, Solinas G, Brescia P, Osti D, Zunino F, Colombo P, Destro A, Roncalli M, Mantovani A, Draghi R, et al: Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1. Eur J Cancer 46: 3383-3392, 2010.
29. Rodero M, Marie Y, Coudert M, Blondet E, Mokhtari K, Rousseau A, Raoul W, Carpentier C, Sennlaub F, Deterre P, et al: Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma. J Clin Oncol 26: 5957-5964, 2008.
30. Babar IA, Czochor J, Steinmetz A, Weidhaas JB, Glazer PM and Slack FJ: Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biol Ther 12: 908-914, 2011.
31. Dolcet X, Llobet D, Pallares J and Matias-Guiu X: NF-kB in development and progression of human cancer. Virchows Arch 446: 475-482, 2005.
32. McComb JG, Ranganathan M, Liu XH, Pilewski JM, Ray P, Watkins SC, Choi AM and Lee JS: CX3CL1 up-regulation is associated with recruitment of CX3CR1+ mononuclear phagocytes and T lymphocytes in the lungs during cigarette smoke-induced emphysema. Am J Pathol 173: 949-961, 2008.
33. Valdivia-Silva JE, Franco-Barraza J, Silva AL, Pont GD, Soldevila G, Meza I and García-Zepeda EA: Effect of proinflammatory cytokine stimulation on human breast cancer: implications of chemokine receptor expression in cancer metastasis. Cancer Lett 283: 176-185, 2009.
34. Shulby SA, Dolloff NG, Stearns ME, Meucci O and Fatatis A: CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells. Cancer Res 64: 4693-4698, 2004.
35. Jamieson WL, Shimizu S, D'Ambrosio JA, Meucci O and Fatatis A: CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism. Cancer Res 68: 1715-1722, 2008.
36. Newman DJ and Cragg GM: Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75: 311-335, 2012.
37. Cragg GM and Newman DJ: Natural products: a continuing source of novel drug leads. Biochim Biophys Acta 1830: 3670-3695, 2013.